Q3 2016 Holdings
Filed 2016-11-08 | 107 holdings | $629.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Threshold Pharmaceuticals | COM | 885807206 | $136.5K | 201,537 | 0.0% |
| Ford Motor Co(F) | COM | 345370860 | $176.4K | 14,611 | 0.0% |
| Jpmorgan Chase & Co(JPM) | COM | 46625H100 | $179.0K | 2,688 | 0.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $180.9K | 3,140 | 0.0% |
| Intl Business Machines Corp(IBM) | COM | 459200101 | $181.6K | 1,143 | 0.0% |
| Exxon Mobil Corp(XOM) | COM | 30231G102 | $183.5K | 2,102 | 0.0% |
| Halliburton Co(HAL) | COM | 406216101 | $189.9K | 4,231 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $192.5K | 5,100 | 0.0% |
| Caterpillar Inc(CAT) | COM | 149123101 | $193.3K | 2,178 | 0.0% |
| Qualcomm Inc(QCOM) | COM | 747525103 | $196.5K | 2,869 | 0.0% |
| Wells Fargo & Co(WFC) | COM | 949746101 | $200.2K | 4,522 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $274.8K | 40,000 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $304.3K | 30,099 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $330.5K | 50,000 | 0.1% |
| Orexigen Therapeutics Inc | COM | 686164302 | $398.4K | 120,000 | 0.1% |
| Mednax Inc(MD) | COM | 58502B106 | $596.3K | 9,000 | 0.1% |
| Catabasis Pharmaceuticals In | COM | 14875P107 | $616.0K | 100,000 | 0.1% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $633.0K | 154,006 | 0.1% |
| Anthera Pharmaceuticals Inc | COM | 03674U201 | $945.0K | 300,000 | 0.2% |
| Regulus Therapeutics Inc | COM | 75915K101 | $990.0K | 300,000 | 0.2% |
| Tetraphase Pharmaceuticals I | COM | 88165N105 | $1.1M | 300,000 | 0.2% |
| Valeant Pharmaceuticals Inte | COM | 91911K102 | $1.2M | 50,000 | 0.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.6M | 50,000 | 0.3% |
| Intercept Pharmaceuticals In(ICPTUSD) | COM | 45845P108 | $1.6M | 10,000 | 0.3% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $1.8M | 15,000 | 0.3% |
| Tandem Diabetes Care Inc | COM | 875372104 | $1.8M | 234,000 | 0.3% |
| Esperion Therapeutics Inc(ESPR) | COM | 29664W105 | $1.8M | 130,000 | 0.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.0M | 40,000 | 0.3% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $2.1M | 135,000 | 0.3% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $2.1M | 130,000 | 0.3% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $2.2M | 104,000 | 0.3% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $2.2M | 266,000 | 0.3% |
| Tesaro Inc | COM | 881569107 | $2.2M | 21,500 | 0.3% |
| Rite Aid Corp | COM | 767754104 | $2.3M | 300,000 | 0.4% |
| Insulet Corp(PODD) | COM | 45784P101 | $2.3M | 57,000 | 0.4% |
| Keryx Biopharmaceuticals | COM | 492515101 | $2.7M | 500,111 | 0.4% |
| Neuroderm Ltd | SHS | M74231107 | $2.7M | 144,546 | 0.4% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $2.7M | 120,805 | 0.4% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $3.0M | 250,000 | 0.5% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $3.0M | 550,000 | 0.5% |
| Dynavax Technologies Corp(DVAX) | COM | 268158201 | $3.1M | 300,000 | 0.5% |
| Perrigo Co Plc(PRGO) | SHS | G97822103 | $3.2M | 35,000 | 0.5% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $3.4M | 210,000 | 0.5% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $3.5M | 131,357 | 0.6% |
| Cooper Cos Inc | COM | 216648402 | $3.6M | 20,000 | 0.6% |
| Nxstage Medical Inc | COM | 67072V103 | $3.6M | 145,300 | 0.6% |
| Davita Inc(DVA) | COM | 23918K108 | $3.6M | 55,000 | 0.6% |
| Universal Health Services(UHS) | COM | 913903100 | $3.7M | 30,000 | 0.6% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $3.7M | 550,000 | 0.6% |
| Cempra Inc | COM | 15130J109 | $3.9M | 161,000 | 0.6% |